Fast Shipping Rabbit Anti Human Smad5 Monoclonal Clone Haf-19 Kit [8SO1VE3f]

Fast Shipping Rabbit Anti Human Smad5 Monoclonal Clone Haf-19 Kit [8SO1VE3f]

The Fast Shipping Rabbit Anti Human Smad5 Monoclonal Clone Haf-19 Kit [8SO1VE3f] from Innovative Research is a premium monoclonal antibody designed for use in research applications. This antibody is specifically engineered to target the phospho-Smad5(S463/S465) epitope, making it an ideal tool for studying signaling pathways in human cells. Crafted with precision, this antibody is available in a convenient liquid format, ensuring easy handling and consistent results across your experiments.

Product Specifications and Features

The Fast Shipping Rabbit Anti Human Smad5 Monoclonal Clone Haf-19 Kit [8SO1VE3f] is produced using a robust rabbit immunization and affinity chromatography purification process. This method ensures high purity and specificity, resulting in a reliable antibody with a concentration of 0.4-0.5mg/ml BSA. The antibody is buffered in phosphate buffered saline (PBS), pH 7.4, with 150mM NaCl, 0.02% sodium azide, and 50% glycerol, providing optimal stability and longevity. This product is suitable for various immunological assays, including immunofluorescence (IF) and Western blot (WB), with recommended dilutions of 1:500-1:1000 for WB and 1:50-1:200 for ICC.

Applications and Benefits

The Fast Shipping Rabbit Anti Human Smad5 Monoclonal Clone Haf-19 Kit [8SO1VE3f] is a versatile tool for researchers studying the SMAD5 signaling pathway and its role in human cellular processes. Its application extends across a wide range of research areas, including oncology, immunology, and developmental biology. By targeting the phospho-Smad5(S463/S465) epitope, this antibody enables detailed investigation into the activation and regulation of SMAD5 in human cells. With its exceptional purity, specificity, and ease of use, this product is a valuable asset for any laboratory seeking to advance their research in the field of cellular signaling and gene expression.